Jane True is vice president for mRNA commercial strategy and innovation and global pandemic security lead at Pfizer, directing a team responsible for mRNA platform, pipeline, and product strategy. True also leads the charge on preparing the global community for future pandemics and achieving pandemic security; she has worked in the pandemic preparedness and medical countermeasures space since just before the 2009 H1N1 pandemic. Previously, she was vice president of commercial development at Seqirus, responsible for portfolio and pipeline strategy, including mRNA and commercial strategy. In her last role, she was also responsible for global marketing, global market access (pricing, HEOR, access, and reimbursement), competitive intelligence, and commercial analytics. True earlier worked in strategy and operations consulting as an independent consultant and with PwC and Capgemini Consulting. (Pfizer is a 2023 Festival Underwriter)
Previously
Scientists and policymakers all agree that another pandemic is inevitable—and that we are still not prepared. Whether it is a COVID mutation, a bird flu, or something entirely...